Obstructive Sleep Apnoea: From pathogenesis to treatment: Current controversies and future directions
- PMID: 20136736
- PMCID: PMC4342116
- DOI: 10.1111/j.1440-1843.2009.01699.x
Obstructive Sleep Apnoea: From pathogenesis to treatment: Current controversies and future directions
Abstract
Obstructive sleep apnoea (OSA) is a common disease, recognized as an independent risk factor for a range of clinical conditions, such as hypertension, stroke, depression and diabetes. Despite extensive research over the past two decades, the mechanistic links between OSA and other associated clinical conditions, including metabolic disorders and cardiovascular disease, remain unclear. Indeed, the pathogenesis of OSA itself remains incompletely understood. This review provides opinions from a number of leading experts on issues related to OSA and its pathogenesis, interaction with anaesthesia, metabolic consequences and comorbidities, cardiovascular disease, genetics, measurement and diagnosis, surgical treatment and pharmacotherapeutic targets.
Conflict of interest statement
Conflict of interest statement: R.L.H., L.P. and M.I. do not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
References
-
- Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med. 2002;165:1217–1239. - PubMed
-
- Alghanim N, Comondore VR, Fleetham J, et al. The economic impact of obstructive sleep apnea. Lung. 2008;186:7–12. - PubMed
-
- Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep. 2006;29:299–305. - PubMed
-
- Heffner JE, Holgate ST, Chung KF, et al. Road ahead to respiratory health: experts chart future research directions. Respirology. 2009;14:625–636. - PubMed
-
- Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–245. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
